በBoston፣ MA ለግሊዎማ የሚደረጉ ክሊኒካዊ ጥናቶች
ለግሊዎማ የሚደረጉ 20 ጥናቶች በBoston እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
MCT for the Harvard/UCSF ROBIN Center
ተሳታዮችን በመፈለግ ላይ
- Brigham and Women's Hospital, Boston
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Dana-Farber Cancer Institute, Boston
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
- Dana Farber Cancer Institute, Boston
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Dana Farber Cancer Institute., Boston
Targeted Pediatric High-Grade Glioma Therapy
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Dana-Farber Cancer Institute, Boston
Study of Olutasidenib and Temozolomide in HGG
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Susan Chi, Boston
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Dana-Farber Cancer Institute, Boston
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Research Site, Boston
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Tufts Medical Center, Boston
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
CARv3-TEAM-E T Cells in Glioblastoma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Massachusetts General Hospital Cancer Center, Boston
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1ጤናማ ተሳታዮች ይቀበላሉ
- Dana-Farber Cancer Institute, Boston
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Dana-Farber Cancer Institute, Boston
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Dana Farber Cancer Institute, Boston
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1
- Dana-Farber Cancer Institute, Boston
rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston
CUE-102 in Recurrent Glioblastoma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
NeuroPathways Intervention for Brain Tumor Patients
ተሳታዮችን በመፈለግ ላይ
- Massachusetts General Hospital Cancer Center, Boston
ASCENT Intervention for Brain Tumor Patients
ተሳታዮችን በመፈለግ ላይ
- Massachusetts General Hospital Cancer Center, Boston
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Massachusetts General Hospital, Boston
በሌሎች ከተሞች ለግሊዎማ የሚደረጉ ጥናቶች
- New York City, NY25 ጥናቶች
- Houston, TX23 ጥናቶች
- Washington, DC19 ጥናቶች
- Philadelphia, PA16 ጥናቶች
- Columbus, OH15 ጥናቶች
- Miami, FL15 ጥናቶች
- San Francisco, CA14 ጥናቶች
- Chicago, IL13 ጥናቶች
- Durham, NC12 ጥናቶች
- Seattle, WA11 ጥናቶች
- Los Angeles, CA10 ጥናቶች
- St. Louis, MO10 ጥናቶች
በBoston ውስጥ ያሉ ሌሎች ጥናቶች
- የጡንቻ ካንሰር111 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር90 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)86 ጥናቶች
- የኮሎሬክታል ካንሰር63 ጥናቶች
- Metastatic Cancer63 ጥናቶች
- የሳንባ ካንሰር62 ጥናቶች
- የእንቁላል ካንሰር61 ጥናቶች
- የፕሮስቴት ካንሰር59 ጥናቶች
- ዲፕሬሽን52 ጥናቶች
- የኤንዶሜትሪየም ካንሰር50 ጥናቶች
- የልብ ድካም44 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ44 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።